Last reviewed · How we verify
NCT07015970: RAPPID
Real-life Follow-up of the Physical Activity in Type 1 Diabetes Participants Equipped With an Insulin Pump With Hybrid Closed Loop
trial testing No Intervention: Observational Cohort in Diabetes Mellitus Type 1 in 87 participants. Completed in 15 December 2024.
15 December 2024
Quick facts
| Lead sponsor | ISIS Diabete Service |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 87 |
| Start date | 5 March 2024 |
| Primary completion | 15 December 2024 |
| Estimated completion | 15 December 2024 |
| Sites | 4 locations across France |
Drugs / interventions tested
- No Intervention: Observational Cohort — full drug profile →
Conditions studied
- Diabetes Mellitus Type 1 — all drugs for Diabetes Mellitus Type 1 →
- Glucose Metabolism Disorder — all drugs for Glucose Metabolism Disorder →
- Glycemic Control for Diabetes Mellitus — all drugs for Glycemic Control for Diabetes Mellitus →
- Fear of Hypoglycemia — all drugs for Fear of Hypoglycemia →
Sponsor
ISIS Diabete Service
Who can join
18 and older, any sex, with Diabetes Mellitus Type 1 or Glucose Metabolism Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a non-interventional, prospective, multi-site study conducted in France among adults with type 1 diabetes mellitus using automated insulin delivery (AID) systems and engaging in at least two exercise sessions per week, each lasting at least 30 minutes. The main objective of this study is to describe the glycemic control of athletic participants with type 1 diabetes mellitus who use an insulin pump with AID and engage in physical exercise under real-life conditions. Two physician data collection time points are planned: the first occurs at baseline and includes demographic and clinical data, glycemic control during the month preceding inclusion, diabetes management, and information on usual physical exercise (duration, type, sport practiced, competition participation, and adherence to a specific diet). The second occurs at 1-month follow-up and involves downloading insulin pump and glucose sensor data, covering the period from 15 days before the first reported exercise session to 15 days after the last session. During the 1-month study period, participants will complete a paper logbook after each exercise session to document information such as the type of exercise, self-reported intensity using the modified Borg scale and the WHO physical activity intensity scale, duration, system adjustments, dietary intake, occurrence of hypoglycemia and associated symptoms, snacks consumed, and treatments administered for hypoglycemia.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Hypoglycemia incidence and behavioural adjustments during free-living unstructured physical activity in adults with type 1 diabetes using AID systems: Results from the RAPPID study.
Joubert M, Meyer L, Bekka S, Rakotoarisoa L, et al · · 2025 · cited 2× · PMID 40926369 · DOI 10.1111/dom.70122
Verify or expand the search:
- PubMed search for NCT07015970
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No Intervention: Observational Cohort
Trials testing the same drug.
- NCT07284771 — MUSCLE-ML: Multimodal Integration of Muscle Strength, Structure by Machine Learning for Precision Rehabilitation After A · not yet recruiting
- NCT07414160 — Association Between Dynamic Prealbumin Trajectories and Prognosis in Critically Ill Patients · not yet recruiting
- NCT07481188 — Frailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery · recruiting
- NCT07475468 — CP382 - Intermittent Catheter (IC) PRO Panel Plan · not yet recruiting
- NCT07382570 — Natural Course of Congenital Hydronephrosis in Infants Aged 0-6 Months · not yet recruiting
Other recruiting trials for Diabetes Mellitus Type 1
Currently open trials in the same condition.
- NCT07091318 — CBTi for the Treatment of Insomnia in Type 1 Diabetes · EARLY_PHASE1 · recruiting
- NCT07320495 — Efficacy and Safety of the APGO Algorithm for Automated Insulin Delivery · NA · recruiting
- NCT06936280 — Type 1 Diabetes and Diabetes Distress · NA · recruiting
Other ISIS Diabete Service trials
Trials by the same sponsor.
- NCT04100070 — Intensive Versus Standard One Year Monitoring on Glycaemic Control After Initiating CSII in Children With DT1. DEEP Stud · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07015970 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ISIS Diabete Service
- Last refreshed: 26 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07015970.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing